reviewDiabetes/Metabolism Research and ReviewsJan 23, 2012Closed access

Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy

Royal Hallamshire Hospital · Sheffield Teaching Hospitals NHS Foundation Trust

Indexed incrossref

Abstract

SUMMARY Diabetic peripheral neuropathy (DPN) affects up to 50% of patients with diabetes and is a major cause of morbidity and increased mortality. Its clinical manifestations include painful neuropathic symptoms and insensitivity, which increases the risk for burns, injuries and foot ulceration. Several recent studies have implicated poor glycaemic control, duration of diabetes, hyperlipidaemia (particularly hypertryglyceridaemia), elevated albumin excretion rate s and obesity as risk factors for the development of DPN. Although there is now strong evidence for the importance of nerve microvascular disease in the pathogenesis of DPN, the risk factors for painful DPN are not known. However, emerging evidence…

Citation impact

608
total citations
FWCI
21.68
Percentile
100%
References
42
Citations per year

Authors

2

Topics & keywords

Keywords
  • Medicine
  • Duloxetine
  • Pregabalin
  • Diabetes mellitus
  • Neuropathic pain
  • Peripheral neuropathy
  • Diabetic neuropathy
  • Tricyclic
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.